bNovate Technologies

About:

bNovate Technologies develops fully automated analysis instruments.

Website: https://www.bnovate.com/

Top Investors: HCLTech, Eurostars, Celeste Management, Emerald Technology Ventures, Ronald Strässler

Description:

bNovate Technologies SA was founded in 2011 with the goal to be the best in the field of automated cells analysis. The company is based at the Innovation Park of the Swiss Federal Institute of Technology of Lausanne (EPFL). They started their activities with a few people. Today, bNovate Technologies SA has grown into a strong team of scientific experts and managers who can address the challenge of developing the most demanding, fully automated analysis instruments. They develop instruments for clients, but they also created their own cell detection instruments for drinking water that they distribute through partnering companies.

Total Funding Amount:

17.2M CHF

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ecublens, Vaud, Switzerland

Founded Date:

2011-01-01

Contact Email:

info(AT)bnovate.com

Founders:

Simon Künzi

Number of Employees:

11-50

Last Funding Date:

2023-06-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai